Program
Betamethasone
Also written as “Ropivacaine + Clonidine + Betamethasone”, “Fixed Dose Etoricoxib + Betamethasone” and “calcipotriol and betamethasone (LEO 80185 gel)”.
Its studies are mostly in Psoriasis · Bursitis · Hip Fractures · Rhinitis, led by 6 companies.
Drug pageBetamethasone: every studyMany companies study it; this page follows only the 8 they lead. All 123 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| LEO Pharmaits history only | 30 open or running | phase 3since Jan 17, 2006 | Jan 17, 2006 | none ahead |
| Abbott | 10 open or running | phase 3since Dec 12, 2007 | Dec 12, 2007 | none ahead |
| Cartivaits history only | 10 open or running | phase 2since Feb 17, 2014 | Feb 17, 2014 | none ahead |
| Laboratorios Silanes S.A. de C.V.its history only | 10 open or running | phase 3since Dec 28, 2025 | Dec 28, 2025 | none ahead |
| Merckits history only | 10 open or running | phase 4since Aug 20, 2009 | Aug 20, 2009 | none ahead |
| Tolmarits history only | 10 open or running | phase 1since Apr 6, 2017 | Apr 6, 2017 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Abbott only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Dec 12, 2007First study: phase 3 study in PsoriasisFirst studyNCT00574249 · 730 enrolled · Austria, Belgium, Czech Republic and more
TargetBeta
“Glucocorticoid receptor agonist”ChEMBL 37, by rule
Other programs on NR3C1
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Dexamethasonerule | AbbVie | phase 4 | 174 |
| Budesoniderule | AstraZeneca | phase 4 | 167 |
| fluticasone furoaterule | GlaxoSmithKline | phase 4 | 97 |
| Prednisonerule | Johnson & Johnson | phase 4 | 65 |
| Beclomethasonerule | Chiesi Farmaceutici | phase 4 | 46 |
| Prednisolonerule | Sanofi | phase 4 | 34 |
| betamethasone dipropionaterule | LEO Pharma | phase 4 | 27 |
| Methylprednisolonerule | Pfizer | phase 4 | 23 |
| dexamethasone phosphaterule | eyegate-pharmaceuticals-inc | phase 4 | 21 |
| Triamcinolonerule | research-insight-llc | phase 4 | 5 |
| relacorilantrule | Corcept Therapeutics | phase 3 | 22 |
| Triamcinolone Acetoniderule | clearside-biomedical-inc | phase 3 | 20 |
Studies
The one study Abbott leads. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT00574249Psoriasis · Austria, Belgium, Czech Republic and more | 3 | Completed | Oct 2008 | 730 |
How it is read
Names in the registry
- “Ropivacaine + Clonidine + Betamethasone”, 3 entries
- “Fixed Dose Etoricoxib + Betamethasone”, 1 entry
- “calcipotriol and betamethasone (LEO 80185 gel)”, 1 entry
- “Calcipotriol plus betamethasone”, 1 entry
- “Calcipotriene/betamethasone gel and ointment”, 1 entry
Conditions, from the studies’ own filings
- Psoriasis, 5 studies
- Bursitis, 1 study
- Hip Fractures, 1 study
- Rhinitis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.